Literature DB >> 29531949

Radioembolization in the setting of liver transplantation: great expectations or hard times?

Quirino Lai1, Gianluca Mennini1.   

Abstract

Year:  2018        PMID： 29531949      PMCID： PMC5835596          DOI： 10.21037/hbsn.2017.12.10

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation.

Authors:  Giovanni Battista Levi Sandri; Giuseppe Maria Ettorre; Marco Colasanti; Edoardo De Werra; Gianluca Mascianà; Daniele Ferraro; Giovanni Tortorelli; Rosa Sciuto; Pierleone Lucatelli; Giuseppe Pizzi; Ubaldo Visco-Comandini; Giovanni Vennarecci
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

2.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

3.  Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.

Authors:  Ahmed Gabr; Nadine Abouchaleh; Rehan Ali; Michael Vouche; Rohi Atassi; Khairuddin Memon; Ali Al Asadi; Talia Baker; Juan Carlos Caicedo; Kush Desai; Jonathan Fryer; Ryan Hickey; Michael Abeccassis; Ali Habib; Elias Hohlastos; Daniel Ganger; Laura Kulik; Robert J Lewandowski; Ahsun Riaz; Riad Salem
Journal:  Eur J Radiol       Date:  2017-05-20       Impact factor: 3.528

4.  Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.

Authors:  Riad Salem; Andrew C Gordon; Samdeep Mouli; Ryan Hickey; Joseph Kallini; Ahmed Gabr; Mary F Mulcahy; Talia Baker; Michael Abecassis; Frank H Miller; Vahid Yaghmai; Kent Sato; Kush Desai; Bartley Thornburg; Al B Benson; Alfred Rademaker; Daniel Ganger; Laura Kulik; Robert J Lewandowski
Journal:  Gastroenterology       Date:  2016-08-27       Impact factor: 22.682

5.  Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib.

Authors:  Michael Vouche; Laura Kulik; Rohi Atassi; Khairuddin Memon; Ryan Hickey; Daniel Ganger; Frank H Miller; Vahid Yaghmai; Michael Abecassis; Talia Baker; Mary Mulcahy; Ritu Nayar; Robert J Lewandowski; Riad Salem
Journal:  Hepatology       Date:  2013-10-01       Impact factor: 17.425

6.  Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres.

Authors:  Ahsun Riaz; Laura Kulik; Robert J Lewandowski; Robert K Ryu; Georgia Giakoumis Spear; Mary F Mulcahy; Michael Abecassis; Talia Baker; Vanessa Gates; Ritu Nayar; Frank H Miller; Kent T Sato; Reed A Omary; Riad Salem
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

Review 7.  Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis.

Authors:  Richard S Finn; Andrew X Zhu; Wigdan Farah; Jehad Almasri; Feras Zaiem; Larry J Prokop; Mohammad Hassan Murad; Khaled Mohammed
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

8.  Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.

Authors:  Riad Salem; Ahmed Gabr; Ahsun Riaz; Ronald Mora; Rehan Ali; Michael Abecassis; Ryan Hickey; Laura Kulik; Daniel Ganger; Steven Flamm; Rohi Atassi; Bassel Atassi; Kent Sato; Al B Benson; Mary F Mulcahy; Nadine Abouchaleh; Ali Al Asadi; Kush Desai; Bartley Thornburg; Michael Vouche; Ali Habib; Juan Caicedo; Frank H Miller; Vahid Yaghmai; Joseph R Kallini; Samdeep Mouli; Robert J Lewandowski
Journal:  Hepatology       Date:  2018-01-29       Impact factor: 17.425

9.  Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

Authors:  Valérie Vilgrain; Helena Pereira; Eric Assenat; Boris Guiu; Alina Diana Ilonca; Georges-Philippe Pageaux; Annie Sibert; Mohamed Bouattour; Rachida Lebtahi; Wassim Allaham; Hélène Barraud; Valérie Laurent; Elodie Mathias; Jean-Pierre Bronowicki; Jean-Pierre Tasu; Rémy Perdrisot; Christine Silvain; René Gerolami; Olivier Mundler; Jean-Francois Seitz; Vincent Vidal; Christophe Aubé; Frédéric Oberti; Olivier Couturier; Isabelle Brenot-Rossi; Jean-Luc Raoul; Anthony Sarran; Charlotte Costentin; Emmanuel Itti; Alain Luciani; René Adam; Maïté Lewin; Didier Samuel; Maxime Ronot; Aurelia Dinut; Laurent Castera; Gilles Chatellier
Journal:  Lancet Oncol       Date:  2017-10-26       Impact factor: 41.316

10.  Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.

Authors:  Young Youn Cho; Minjong Lee; Hyo-Cheol Kim; Jin Wook Chung; Yun Hwan Kim; Geum-Youn Gwak; Si Hyun Bae; Do Young Kim; Jeong Heo; Yoon Jun Kim
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.